The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Pain Therapeutics  (PTIE) Trade Now »     Rate PTIE  -  Discuss PTIE  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
83.0%
Top:
100.0%
Rate PTIE:



PTIE Analysis & Videos »


PTIE: Bull or Bear?

FDA, Clinical Trial Calendars: Nine Cash Plus Catalyst Trades Graphic_rating_buy PTIE
Mikerun
73%
 +13.65%
in 200 days
Below are nine 'Cash Plus Catalyst' trades which include companies that are currently trading for around 2X net cash/equivalents or less (the ratio of market cap to cash/equivalents less debt) with pending FDA decisions, clinical trial results, or pending FDA submissions. <font> Click here for a link </font> to the BioMedReports FDA and Clinical Trial Calendars page.
 
<> 1.) BioForm Medical (NASDAQ:BFRM) : Market Cap = $59.8M, Net Cash = $41.4M. In March 2009, BioForm Medical announced the results of a clinical trial evaluating the mixing of lidocaine with RADIESSE derma...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/09/09 Comment


FDA Decision Calendar: Pain Drug Delays Likely PTIE
Mikerun
73%
 -31.45%
in 88 days
(closed on 05/09/09)
FDA Decision Calendar: Pain Drug Delays Likely
By Mike Havrilla on 2/9/09
ETF Innovators
 
The tables at my website link below include an updated calendar of 86 expected FDA new product decisions and 89 pending clinical trial result estimates + pending FDA re-submissions or new submissions for regulatory approval. Click here for a link to my previous calendars.
 
 
New FDA Decision Calendar Entries:
 
<> 1.) Biogen Idec (BIIB) and Genentech (DNA) have a PDUFA...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/10/09 Comment


More Pain to Come from the FDA? Graphic_rating_buy PTIE
Mikerun
73%
 -3.37%
in 22 days
(closed on 11/13/08)

More Pain to Come from the FDA?

<>
The accompanying table (click on image to enlarge) presents an updated calendar of expected FDA decision dates. Surprisingly, the FDA issued a complete response letter to Abbott Labs (ABT) for Vicodin CR, an extended-release version of the widely used painkiller that the company expected to be approved this quarter. Three more companies face key FDA decision in the month of December for abuse-resistant forms of opiate pain drug candidates. King Pharma (KG) and Pain Therapeutics (PTIE) await a decision on Remoxy while Alpharma (ALO) ...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/22/08 Comment


Get free stock alert for PTIE:
Your Email Address:


FDA Decision Date Calendar for 2009 Graphic_rating_buy PTIE
Mikerun
73%
 -0.33%
in 28 days
(closed on 10/22/08)

FDA Decision Date Calendar for 2009

<>
<> <> <> The accompanying table presents a calendar of expected FDA regulatory approval decisions for 2009, including a March 1st deadline to expand the label of cancer drug Erbitux in what has now become a hostile takeover attempt by Bristol-Myers (BMY) for the remaining 83% stake in ImClone Systems (IMCL) it does not already own. Two other companies which are highly leveraged to their upcoming FDA decision include Pain Therapeutics (PTIE) and King Pharma (KG) for Remoxy, which are due to hear back from the agency this yea...
By  Mike Havrilla   (+1.04%  risk: conservative)  09/24/08 Comment


Questions on Pain Thera's Remoxy PTIE
-36.45%
in 501 days
Our main concern right now is the possibility of the company facing a patent infringement lawsuit for the drug. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect.
By  Zacks.com   (-13.51%  risk: moderate)  07/11/08 Comment





People Bullish on PTIE

Mikerun
Mike Havrilla
Principal
73%
6 mos ago

chuchogold
Analyst
28%
over 2 years ago


People Bearish on PTIE

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.37% 379
2 Gerald Greene 18.14 +70.70% 209
3 stockmarketfunding.com 17.66 +25.67% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +78.05% 39


POPULAR STOCKS
Symbol Company Name Sentiment
DRYS DryShips Inc.
POT Potash Corp. of Saskatchewan Inc.
DELL Dell Inc
AIG American International Group Inc.
GS Goldman Sachs Group Inc The
NVDA NVIDIA Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on PTIE


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Pain Therapeutics - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch